The latest annual National Statistics on waiting times for suspected and diagnosed cancer patients accessing NHS services, produced by NHS England, were released on 25 July 2014 according to the arrangements approved by the UK Statistics Authority.
In partnership with the Association of Breast Surgery and Breakthrough Breast Cancer, Breast Cancer Campaign is part-funding a Breast Surgical Specialty Lead in the Royal College of Surgeons Clinical Trials Initiative.
Research has shown that statins could be used to reduce the risk of developing breast cancer after a link between the illness and high cholesterol was found in a study of more than 1 million patients over a 14 year time period in the UK.
For the first time, researchers, funded by Breast Cancer Campaign, have shown that the molecule αvβ6 (alpha v beta 6) plays a fundamental role in helping breast cancer cells to grow and spread - and that the molecule is a viable new target for treating one of the most aggressive types of breast cancer.
Breast Cancer Campaign is a charity registered by the Charity Commission for England and Wales (no. 299758) and a company limited by guarantee registered in England (no. 05074725) whose registered office is at Clifton Centre, 110 Clifton Street, London EC2A 4HT.